Kéryanne Gagnon

Targeting TMEM16F‑Driven Membrane Remodeling: A Promising Strategy for Broad-Spectrum Antiviral Development

With the continuous rise of epidemics with potential for global threats, the need for antiviral drug development continues to be essential. Most drugs approved by the Food and Drug Administration (FDA) are direct-acting agents (DAAs), targeting specific viral proteins, thus restr...